November 1, 2024
BERLIN — Technological advancements and the development of intraocular lenses (IOLs) have significantly improved the care of patients with cataracts, especially for those who would prefer […]
October 30, 2024
A proposal to close the National Eye Institute (NEI) and consolidate it with two other arms of the US National Institutes of Health (NIH) has brought […]
October 22, 2024
TOPLINE: Patients with dry eye disease are more than three times as likely to have mental health conditions, such as depression and anxiety, as those without […]
October 22, 2024
CHICAGO — A post-market study of the retina drug faricimab that enrolled only minority populations historically underrepresented in drug clinical trials found Hispanic and Latino patients […]
October 21, 2024
TOPLINE: In 2022, an estimated 4.22 million US adults had glaucoma and nearly 1.5 million of them experienced some vision loss as a result, with notable […]
October 17, 2024
TOPLINE: BARCELONA, Spain — Patients who receive a diagnosis of neovascular age-related macular degeneration (nAMD) from their primary care clinician may be less likely to adhere […]
October 16, 2024
BARCELONA, Spain — Ophthalmology has lagged far behind other specialties in adopting automated technology for the operating room, but a team of researchers in California has […]
October 4, 2024
The only approved ocular gene therapy, which targets a specific gene mutation in two forms of inherited retinal disease, has shown evidence in a real-world study […]
October 3, 2024
BARCELONA, Spain — Early findings from a real-world study of the dual-action antibody faricimab have shown sustained improvement in visual acuity and key biomarkers of retinal […]